Zebra Technologies has underperformed the broader S&P 500 over the past year, though analysts continue to maintain a ...

Greetings, and welcome to Digimarc Corporation's Fourth Quarter 2025 Earnings Q&A Call. [Operator Instructions] Please note, this call is being recorded. I will now turn the conference over to Charles ...

Frankfurt-based Bookwire acquires 100% of Berlin-based digital distributor Zebralution’s shares from German rights collection ...

Officials with the FDA have approved a label expansion for fluralaner for extended-release injectable suspension (Bravecto ...

Neo4j Aura Agent is an end-to-end platform for creating agents, connecting them to knowledge graphs, and deploying to ...

The abolishment of the data vacuum between the warehouse and the customer characterizes the Future of Retail. Smart Shelves, ...

It’s hard to deny that label printers have become more accessible than ever, but an annoying aspect of many of these cheap units is that their only user interface is a proprietary smartphone ...

The US FDA has recently proposed a new draft framework that enables pharma manufacturers to add software to a drug label if they can demonstrate that the software adds clinical benefit to the drug.

Digimarc (NASDAQ:DMRC) executives used a rescheduled fourth quarter 2025 earnings Q&A call to address investor questions focused largely on the company’s gift card initiative and several other recent ...

The deal arrives less than two months after GEMA sold Zebralution to New York-based private equity firm Insight Holdings ...